BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Endocrinology

Certa Therapeutics Strengthens Asia-Pacific Leadership with Acquisition of Melbourne-Based OccuRx to Advance GPR68-Driven Fibrotic Disease Therapies

Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with fibrotic diseases, today announces the acqu...

December 19, 2024 | News

Hansa Biopharma Completes Phase 3 Trial Enrollment Ahead of Schedule for Rare Autoimmune Disease

Hansa Biopharma, "Hansa" announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a global pivotal Phase 3 trial in anti-glomerular ...

December 06, 2024 | News

Everest Medicines' NEFECON® Gains Full Approval in South Korea for IgA Nephropathy Treatment

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

November 19, 2024 | News

KARL STORZ and FUJIFILM Healthcare Partner to Enhance GI Endoscopy and OR Integration

KARL STORZ United States, a global leader in Operating Room (OR) integration, has teamed up with FUJIFILM Healthcare Americas Corporation (Fujifilm), a lea...

August 27, 2024 | News

Beyond Medical Group Singapore and SingMed Cambodia Forge Strategic Partnership to Elevate Healthcare Standards in the Region

Beyond Medical Group Singapore and SingMed (Phnom Penh, Cambodia) proudly announce the signing of a Memorandum of Understanding (MOU), marking a...

August 15, 2024 | News

Integra LifeSciences Completes Acquisition of Acclarent, Expands Market Reach in ENT Surgical Solutions

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, announced it has successfully completed it...

April 02, 2024 | News

Chipscreen Biosciences Announces Successful Phase II Trial of Chiglitazar for NASH Treatment

The CGZ203 study, a randomized, double-blind, placebo-controlled trial conducted across 24 national clinical sites, aimed to assess the saf...

March 19, 2024 | News

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

February 13, 2024 | News

Agilis Robotics Reveals Innovative Breakthroughs in Endoluminal Surgery

This achievement empowers surgeons to perform intricate tissue resection procedures with precision and ease, directly within natural orifices. Uniquely, th...

February 05, 2024 | News

Allied Digestive Health and Provation Sign Agreement for Enhanced Patient Care

Allied Digestive Health (ADH), the beacon of cutting-edge gastroenterology (GI) services across New Jersey and New York, is joining forces with Provation, ...

January 22, 2024 | News

Canon Medical and Olympus Form Endoscopic Ultrasound Systems Alliance

Canon Medical has a history of more than 100 years in the diagnostic imaging systems business, including X-ray diagnostic systems, CT, MRI, and ultrasound ...

January 16, 2024 | News

Everest Medicines' Partner Calliditas Announces Nefecon® as Sole FDA-Approved Treatment for Slowing IgA Nephropathy Kidney Decline

The FDA approval is for adults with primary IgAN who are at risk for disease progression, irrespective of proteinuria levels. Nefecon® is now a...

December 21, 2023 | News

AbbVie's SKYRIZI® Outperforms STELARA® in Crohn's Disease Study

SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active ...

October 16, 2023 | News

Metabolon Introduces Liver and Kidney Panels for Disease Research

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...

October 13, 2023 | News

Stay Connected